tert-Butyl 4-amino-4-carbamoylpiperidine-1-carboxylate, 95.0%, 5g

(3aR,4S,7aR)-4-(m-tolylethynyl)octahydro-1H-indol-4-ol hydrochloride, 98%, 50mg

tert-Butyl (S)-2-((tert-butoxycarbonyl)amino)pent-4-enoate, 98%, 1g

4-bromo-2-methylpyridine hydrobromide, 95.0%, 10g

Capping reagent II, 200 ml

4-METHOXYCYCLOHEXANONE ETHYLENE KETAL, 95.0%, 1g

Ethyl 3-amino-3-methylbutanoate hydrochloride, 95.0%, 5g

Naphthylene-2-acetylene, 98.0%, 1g

Ethyl 2-hydroxy-4-methylpyrimidine-5-carboxylate, 95.0%, 5g

Petri dishes divided into 2 compartments, Non sterile 480 pcs

(2-Fluoro-4-isopropoxyphenyl)boronic acid, 95.0%, 10g

(3R,4S,5S,7aR)-3,5,6,7a-Tetramethyl-1-oxo-N,N-diphenyl-1,3,3a,4,5,7a-hexahydroisobenzofuran-4-carboxamide, 97%, 25mg

2-Chloro-6,7-difluoroquinoxaline, 98+%, 250mg